<GlossaryTerm id="CDR0000777066"><TermName>Ninlaro</TermName><TermPronunciation>(nin-LAR-oh)</TermPronunciation><TermDefinition><DefinitionText>A drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who received at least one other anticancer treatment. It is also being studied in the treatment of other types of cancer. Ninlaro blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called ixazomib citrate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000778405" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ninlaro&quot;" language="en" id="_3"/><MediaLink ref="CDR0000778404" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ninlaro&quot;" language="es" id="_4"/><SpanishTermName>Ninlaro</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa con lenalidomida y dexametasona para el tratamiento del mieloma múltiple. Se usa en pacientes que ya recibieron por lo menos otro tratamiento contra el cáncer. También está en estudio para el tratamiento de otros tipos de cáncer. Ninlaro bloquea la acción de un conjunto de enzimas llamado proteasoma, lo que quizás ayude a impedir la multiplicación de células cancerosas y las destruya. Es un tipo de inhibidor del proteasoma. También se llama citrato de ixazomib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2015-11-30</DateFirstPublished><DateLastModified>2021-09-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000777141" url="/about-cancer/treatment/drugs/ixazomibcitrate">Ixazomib Citrate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
